Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up
β Scribed by E. O. MORAIS; M. R. RESENDE; A. M. OLIVEIRA; V. M. SINKOC; M. T. GARCIA; R. N. ANGERAMI; L. J. DA SILVA
- Book ID
- 108604874
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 460 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sera from 79 patients with acute self-limiting hepatitis, 17 patients with acute hepatitis B evolving into chronic HBsAg carriership, and 43 chronic HBsAg carriers without a history of acute hepatitis were analyzed for presence of hepatitis B virus (HBV)-DNA by a molecular hybridization technique. I
## Abstract To evaluate therapeutic immunostimulation nine chronic hepatitis B patients received six monthly intradermal vaccinations with HBsAg in combination with daily lamivudine. Another five patients received six doses of the vaccine and daily lamivudine together with daily Interleukinβ2 (ILβ2
Hepatitis B virus (HBV) markers were determined in 821 patients receiving renal allografts and undergoing immunosuppressive therapy during [1970][1971][1972][1973][1974][1975][1976][1977][1978][1979][1980][1981][1982][1983][1984][1985][1986]. Twenty-four of the patients with a renal transplant funct